CCN2, as observed in breast cancer, CCN3 and CCN4 levels are up regulated in prostate cancer and bone-metastatic cells or corresponding bone metastasis (Dankner et al. 2019; Kim et al. 2020; Ono et al. 2013). Here, CCN4 is linked to prostate cancer.